Robust Activity of Avapritinib, Potent and Highly Selective Inhibitor of Mutated KIT, in Patient-derived Xenograft Models of Gastrointestinal Stromal TumorsYemarshet K. Gebreyohannes, Patrick Schöffski|Clinical Cancer Research|2018Cited by 77
Cabozantinib Is Active against Human Gastrointestinal Stromal Tumor Xenografts Carrying Different <i>KIT</i> MutationsYemarshet K. Gebreyohannes, Agnieszka Woźniak|Molecular Cancer Therapeutics|2016Cited by 32